Literature DB >> 33632257

Two-stage laparoscopic resection of giant hepatoblastoma in infants combined with liver partial partition and artery ligation.

Yaohao Wu1, Lexiang Zeng1, Ronglin Qiu1, Jie Zhang1, Jianhang Su1, Minyi Liao1, Xiaogeng Deng2.   

Abstract

PURPOSE: Laparoscopic resection of giant hepatoblastoma (HB) in children has long been a subject of controversy. Here, a new procedure of two-stage laparoscopic resection of giant HB in infants was firstly reported and the feasibility was discussed.
METHODS: The clinical data of three infants with HB were retrospectively reviewed, all of which received 3-5 cycles of neoadjuvant chemotherapy. Stage 1 laparoscopic selective hepatic artery ligation and liver partial partition were performed. Stage 2 laparoscopic hepatectomy was performed 2 weeks later.
RESULTS: The results demonstrated that (1) the tumors shrank considerably in size and had relatively clear boundaries after neoadjuvant chemotherapy; (2) after stage 1 surgery, the tumor volume further reduced, while the intratumoral necrosis expanded; (3) 2 weeks later, stage 2 laparoscopic hepatectomy was performed successfully; (4) none of the cases had intraoperative complications such as tumor rupture, air embolism, hemorrhage, biliary fistula, or liver failure, and there was no recurrence or metastasis during follow-up.
CONCLUSIONS: Two-stage laparoscopic hepatectomy associating selective hepatic artery ligation and liver partial partition for HB in infants has the benefits of small invasiveness, fast recovery, improved safety, and high feasibility. However, more cases and longer follow-up are needed to assess its long-term efficacy.

Entities:  

Keywords:  Hepatoblastoma; Infant; Laparoscopy; Staged surgery

Mesh:

Year:  2021        PMID: 33632257      PMCID: PMC7908728          DOI: 10.1186/s12957-021-02156-y

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  24 in total

1.  Port-site metastasis after laparoscopic biopsy of a posttransplant Burkitt lymphoma in a child.

Authors:  M Metzelder; B Ure
Journal:  Eur J Pediatr Surg       Date:  2008-12-08       Impact factor: 2.191

2.  The blood supply of neoplasms in the liver.

Authors:  C BREEDIS; G YOUNG
Journal:  Am J Pathol       Date:  1954 Sep-Oct       Impact factor: 4.307

3.  Laparoscopic nephroureterectomy for Wilms' tumor: oncologic considerations.

Authors:  Patrick J Javid; Thomas S Lendvay; Stephanie Acierno; Kenneth W Gow
Journal:  J Pediatr Surg       Date:  2011-05       Impact factor: 2.545

4.  Metabolomics study of the metabolic changes in hepatoblastoma cells in response to NTCP/SLC10A1 overexpression.

Authors:  Jing Wang; Ruicheng Tian; Yuhua Shan; Jingjing Li; Hongxiang Gao; Chenjie Xie; Yimei Ma; Yun Wu; Bin Ji; Song Gu; Min Xu
Journal:  Int J Biochem Cell Biol       Date:  2020-05-22       Impact factor: 5.085

5.  Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

Authors:  J Brown; G Perilongo; E Shafford; J Keeling; J Pritchard; P Brock; C Dicks-Mireaux; A Phillips; A Vos; J Plaschkes
Journal:  Eur J Cancer       Date:  2000-07       Impact factor: 9.162

6.  ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration.

Authors:  Andrea Schlegel; Mickael Lesurtel; Emmanuel Melloul; Perparim Limani; Christoph Tschuor; Rolf Graf; Bostjan Humar; Pierre A Clavien
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

7.  New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.

Authors:  Katarzyna B Hooks; Jérôme Audoux; Helena Fazli; Sarah Lesjean; Tony Ernault; Nathalie Dugot-Senant; Thierry Leste-Lasserre; Martin Hagedorn; Benoit Rousseau; Coralie Danet; Sophie Branchereau; Laurence Brugières; Sophie Taque; Catherine Guettier; Monique Fabre; Anne Rullier; Marie-Annick Buendia; Thérèse Commes; Christophe F Grosset; Anne-Aurélie Raymond
Journal:  Hepatology       Date:  2018-05-14       Impact factor: 17.425

8.  Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors.

Authors:  Sabine Irtan; Hervé J Brisse; Véronique Minard-Colin; Gudrun Schleiermacher; Sandra Canale; Sabine Sarnacki
Journal:  Pediatr Blood Cancer       Date:  2014-10-04       Impact factor: 3.167

9.  Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response?

Authors:  Rocío García-Pérez; Beatriz Revilla-Nuin; Carlos M Martínez; Angel Bernabé-García; Alberto Baroja Mazo; Pascual Parrilla Paricio
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

10.  Prognostic Factors for Event-Free Survival in Pediatric Patients with Hepatoblastoma Based on the 2017 PRETEXT and CHIC-HS Systems.

Authors:  Hee Mang Yoon; Jisun Hwang; Kyung Won Kim; Jung-Man Namgoong; Dae Yeon Kim; Kyung-Nam Koh; Hyery Kim; Young Ah Cho
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

View more
  1 in total

1.  Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with Ferroptosis.

Authors:  Jing-Xiao Li; Jin-Shu Pang; Bin-Tong Yin; Gang Chen; Jun-Hong Chen; Jia-Yuan Luo; Xia Yang; Li-Ting Qin; Jiang-Hui Zeng; Peng Chen; Jia-Bo Chen; Deng Tang
Journal:  Int J Gen Med       Date:  2021-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.